Serial changes on quantitative myocardial perfusion SPECT in patients undergoing revascularization or conservative therapy

被引:30
作者
Berman, DS
Kang, XP
Schisterman, EF
Gerlach, J
Kavanagh, PB
Areeda, JS
Sharir, T
Hayes, SW
Shaw, LJ
Lewin, HC
Friedman, JD
Miranda, R
Germano, G
机构
[1] Cedars Sinai Med Ctr, Dept Imaging, Div Nucl Med, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Dept Med, Div Cardiol, Los Angeles, CA 90048 USA
[3] Cedars Sinai Med Ctr, Burns & Allen Res Inst, Los Angeles, CA 90048 USA
[4] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA
[5] Univ Calif Los Angeles, Sch Med, Dept Biostat, Los Angeles, CA USA
[6] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA
关键词
quantitative myocardial perfusion single photon emission computed tomography; conservative therapy; coronary revascularization; coronary artery disease;
D O I
10.1067/mnc.2001.113991
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Little is known about changes of myocardial perfusion in patients undergoing coronary revascularization or medical therapy. The purpose of this observational study was to assess the long-term effects of revascularization or conservative therapy on serial quantitative myocardial perfusion single photon emission computed tomography (SPECT). Methods and Results. The study population consisted of 421 patients who underwent serial rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion SPECT with at least a 1-year interval between the 2 studies and who had abnormal quantitative scan results on the first stress SPECT. The mean interval between scans was 32.7 +/- 15.9 months. Patients were divided into 3 groups according to stress defect extent: group I had small stress defects (4%-10%, n = 145), group 2 had intermediate stress defects (>10%-20%, n = 144), and group 3 had extensive stress defects (>20%, n = 132) at baseline. Forty patients in group 1, 44 in group 2, and 54 in group 3 underwent coronary revascularization between 2 SPECT studies; the others had conservative therapy. In group 3 patients with revascularization, stress defect extent and reversible defect extent were remarkably reduced (14.5% +/- 13.6% and 13.1% +/- 12.5%, respectively; both P < .0001), with greater improvement in those patients reporting increased use of cardiac medications; resting defect extent was slightly reduced (1.9% <plus/minus> 6.4%, P < .05). In group 3 patients with conservative therapy, a small reduction in stress defect extent was noted (2.3% <plus/minus> 8.3%, P < .05). In group 2, there were modest, similar reductions in reversible defect extent in both the patients with revascularization (2.7% <plus/minus> 7.7%, P < .05) and those with conservative therapy (1.8% <plus/minus> 7.3%, P < .05), as well as a small but significant reduction in stress defect extent in those with conservative therapy (2.1% <plus/minus> 8.2 %, P < .05). In group 1 patients, no significant changes in stress, rest, or reversible defect extent were found with either therapy. Conclusions. The findings of this study show that improvement in quantitative myocardial perfusion abnormalities over time occurs in some patients with either revascularization or conservative therapy and suggest that, in patients with extensive defects, greater improvement may be seen in those who undergo revascularization.
引用
收藏
页码:428 / 437
页数:10
相关论文
共 39 条
[1]  
Alderman EL, 1996, NEW ENGL J MED, V335, P217
[2]   Adenosine technetium-99m sestamibi myocardial perfusion SPECT in women: Diagnostic efficacy in detection of coronary artery disease [J].
Amanullah, AM ;
Kiat, H ;
Friedman, JD ;
Berman, DS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (04) :803-809
[3]   SEPARATE ACQUISITION REST THALLIUM-201/STRESS TC-99M SESTAMIBI DUAL-ISOTOPE MYOCARDIAL PERFUSION SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY - A CLINICAL VALIDATION-STUDY [J].
BERMAN, DS ;
KIAT, H ;
FRIEDMAN, JD ;
WANG, FP ;
VANTRAIN, K ;
MATZER, L ;
MADDAHI, J ;
GERMANO, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (05) :1455-1464
[4]   INCREMENTAL VALUE OF PROGNOSTIC TESTING IN PATIENTS WITH KNOWN OR SUSPECTED ISCHEMIC-HEART-DISEASE - A BASIS FOR OPTIMAL UTILIZATION OF EXERCISE TC-99M SESTAMIBI MYOCARDIAL PERFUSION SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY [J].
BERMAN, DS ;
HACHAMOVITCH, R ;
KIAT, H ;
COHEN, I ;
CABICO, JA ;
WANG, FP ;
FRIEDMAN, JD ;
GERMANO, G ;
VANTRAIN, K ;
DIAMOND, GA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (03) :639-647
[5]   CORONARY ANGIOGRAPHIC CHANGES WITH LOVASTATIN THERAPY - THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY (MARS) [J].
BLANKENHORN, DH ;
AZEN, SP ;
KRAMSCH, DM ;
MACK, WJ ;
CASHINHEMPHILL, L ;
HODIS, HN ;
DEBOER, LWV ;
MAHRER, PR ;
MASTELLER, MJ ;
VAILAS, LI ;
ALAUPOVIC, P ;
HIRSCH, LJ .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (10) :969-976
[6]  
BONOW RO, 1996, AM J MED, V101
[7]  
Brown BG, 2000, CIRCULATION, V102, P506
[8]  
Chuang-Stein C, 1997, Stat Methods Med Res, V6, P115, DOI 10.1191/096228097671068522
[9]   Stress radionuclide studies after acute myocardial infarction: Changes with revascularization [J].
ComaCanella, I ;
Gomez, MD ;
Salazar, L ;
Gallardo, F .
JOURNAL OF NUCLEAR CARDIOLOGY, 1996, 3 (05) :403-409
[10]  
Cuocolo A, 1997, J NUCL MED, V38, P1684